DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,109 filers reported holding DANAHER CORPORATION in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,175,255 | -1.7% | 4,737 | -4.9% | 0.05% | +2.1% |
| Q2 2023 | $1,195,000 | -12.0% | 4,979 | -7.6% | 0.05% | -13.0% |
| Q1 2023 | $1,358,000 | +55.4% | 5,389 | +63.7% | 0.05% | +58.8% |
| Q4 2022 | $874,000 | -46.0% | 3,293 | -47.5% | 0.03% | -50.7% |
| Q3 2022 | $1,618,000 | -20.6% | 6,267 | -22.1% | 0.07% | -15.9% |
| Q2 2022 | $2,038,000 | -16.2% | 8,041 | -3.1% | 0.08% | -1.2% |
| Q1 2022 | $2,433,000 | -7.6% | 8,296 | +3.7% | 0.08% | 0.0% |
| Q4 2021 | $2,632,000 | +303.7% | 8,000 | +172.8% | 0.08% | +277.3% |
| Q4 2020 | $652,000 | -10.3% | 2,933 | -13.1% | 0.02% | -18.5% |
| Q3 2020 | $727,000 | +14.1% | 3,376 | -6.2% | 0.03% | +12.5% |
| Q2 2020 | $637,000 | -12.1% | 3,601 | -31.2% | 0.02% | -14.3% |
| Q1 2020 | $725,000 | -35.6% | 5,237 | -28.7% | 0.03% | -22.2% |
| Q4 2019 | $1,126,000 | -30.4% | 7,340 | -34.4% | 0.04% | -32.1% |
| Q3 2019 | $1,617,000 | -2.6% | 11,195 | -3.6% | 0.05% | 0.0% |
| Q2 2019 | $1,660,000 | -5.2% | 11,615 | -12.4% | 0.05% | -5.4% |
| Q1 2019 | $1,751,000 | +21.7% | 13,263 | -4.9% | 0.06% | +14.3% |
| Q4 2018 | $1,439,000 | +585.2% | 13,952 | +417.9% | 0.05% | +512.5% |
| Q4 2016 | $210,000 | -98.2% | 2,694 | -98.1% | 0.01% | -98.2% |
| Q3 2016 | $11,408,000 | -22.3% | 145,528 | +0.1% | 0.45% | -26.3% |
| Q2 2016 | $14,682,000 | +5.3% | 145,366 | -1.1% | 0.61% | +4.6% |
| Q1 2016 | $13,937,000 | +395.1% | 146,923 | +384.7% | 0.58% | +395.8% |
| Q4 2015 | $2,815,000 | -1.2% | 30,312 | -17.9% | 0.12% | +0.9% |
| Q4 2013 | $2,849,000 | – | 36,910 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |